Stay updated on Safety of Subcutaneous SHR-1209 in Hyperlipidemia Clinical Trial
Sign up to get notified when there's something new on the Safety of Subcutaneous SHR-1209 in Hyperlipidemia Clinical Trial page.

Latest updates to the Safety of Subcutaneous SHR-1209 in Hyperlipidemia Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedMajor update to page content reflecting current operating status and a version bump to v3.2.0; removes the old v3.1.0 reference.SummaryDifference13%
- Check18 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0, indicating a newer release.SummaryDifference0.3%
- Check25 days agoNo Change Detected
- Check33 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2 and the ‘Back to Top’ element was removed. Overall, these are minor UI/versioning changes with no impact on core content, pricing, availability, or scheduling.SummaryDifference0.8%
- Check40 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.SummaryDifference0.8%
- Check47 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location, while several location-related terms have been removed.SummaryDifference7%
- Check61 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.3%
Stay in the know with updates to Safety of Subcutaneous SHR-1209 in Hyperlipidemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Subcutaneous SHR-1209 in Hyperlipidemia Clinical Trial page.